Norges Bank’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-86,200
| Closed | -$547K | – | 94 |
|
|
2024
Q2 | $547K | Buy |
+86,200
| New | +$547K | ﹤0.01% | 1872 |
|
|
2023
Q2 | – | Sell |
-71,100
| Closed | -$98.8K | – | 2014 |
|
|
2023
Q1 | $98.8K | Sell |
71,100
-2,643,300
| -97% | -$3.67M | ﹤0.01% | 2084 |
|
|
2022
Q4 | $5.4M | Buy |
+2,714,400
| New | +$5.4M | ﹤0.01% | 1759 |
|
|
2022
Q2 | – | Sell |
-439,257
| Closed | -$1.83M | – | 2061 |
|
|
2022
Q1 | $1.83M | Sell |
439,257
-241,452
| -35% | -$1.01M | ﹤0.01% | 1990 |
|
|
2021
Q4 | $3.26M | Sell |
680,709
-80,544
| -11% | -$386K | ﹤0.01% | 1981 |
|
|
2021
Q3 | $4.07M | Hold |
761,253
| – | – | ﹤0.01% | 1957 |
|
|
2021
Q2 | $3.9M | Sell |
761,253
-46,653
| -6% | -$239K | ﹤0.01% | 1941 |
|
|
2021
Q1 | $5.44M | Sell |
807,906
-286,048
| -26% | -$1.93M | ﹤0.01% | 1896 |
|
|
2020
Q4 | $5M | Hold |
1,093,954
| – | – | ﹤0.01% | 1869 |
|
|
2020
Q3 | $4.25M | Buy |
1,093,954
+25,699
| +2% | +$99.7K | ﹤0.01% | 1893 |
|
|
2020
Q2 | $5.09M | Sell |
1,068,255
-59,249
| -5% | -$282K | ﹤0.01% | 1863 |
|
|
2020
Q1 | $3.92M | Buy |
1,127,504
+62,893
| +6% | +$219K | ﹤0.01% | 1860 |
|
|
2019
Q4 | $5.13M | Sell |
1,064,611
-371,481
| -26% | -$1.79M | ﹤0.01% | 1910 |
|
|
2019
Q3 | $4.17M | Buy |
1,436,092
+87,719
| +7% | +$254K | ﹤0.01% | 1930 |
|
|
2019
Q2 | $9.67M | Hold |
1,348,373
| – | – | ﹤0.01% | 1812 |
|
|
2019
Q1 | $19.1M | Hold |
1,348,373
| – | – | 0.01% | 1533 |
|
|
2018
Q4 | $18.2M | Buy |
1,348,373
+109,517
| +9% | +$1.48M | 0.01% | 1461 |
|
|
2018
Q3 | $27.5M | Buy |
1,238,856
+115,826
| +10% | +$2.57M | 0.01% | 1325 |
|
|
2018
Q2 | $18.4M | Buy |
+1,123,030
| New | +$18.4M | 0.01% | 1577 |
|